|

reparixin Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Icahn School of Medicine at Mount Sinai1

Indications

  • Post Polycythemia Vera Related Myelofibrosis (PV-MF)1
  • Post Essential Thrombocythemia Myelofibrosis (ET-MF)1
  • Myelofibrosis (PMF)1
  • Cancer1

Tampa, Florida1 trial

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.